InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.70
(
0.13%
)
US TECH 100
17,612.80
(
0.00%
)
Dow Jones
38,884.26
(
0.08%
)
Brent Oil
82.03
(
-1.01%
)
Bitcoin
62,069.38
(
-0.43%
)
Post# of 1076
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BooDog

Send PM Follow Ignore
Followers 229
Posts 21457
Boards Moderated 2
Alias Born 08/03/2006

BooDog

Re: None

Tuesday, 11/09/2010 11:49:48 AM

Tuesday, November 09, 2010 11:49:48 AM

Post# of 1076
9:03AM ACADIA Pharmaceuticals awarded $300K Grant from The Michael J. Fox Foundation for the development of novel Nurr1-RXR agonists to treat parkinson's disease (ACAD) 0.71 :

ACADIA Pharmaceuticals Inc.(NasdaqGM: ACAD)
Real Time 0.7389 0.0236 (3.30%) 11:45AM EST

Last Trade: 0.7358
Trade Time: 11:28AM EST
Change: 0.0205 (2.87%)
Prev Close: 0.72
Open: 0.72
Bid: 0.7358 x 100
Ask: 0.7359 x 200
1y Target Est: 1.50
Day's Range: 0.70 - 0.7380
52wk Range: 0.70 - 2.00
Volume: 112,274
Avg Vol (3m): 265,138
Market Cap: 28.23M
P/E (ttm): N/A
EPS (ttm): -0.72
Div & Yield: N/A (N/A


Do your research! Play the TA. All posts are my opinion.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up